Dr. Veda Giri on Diversity in Clinical Trials

Transcript

• 00:00It is so important to address
• 00:03disparities when it comes to cancer care,
• 00:06and this actually is incredibly
• 00:08important when we think about
• 00:10patients with early onset cancers.
• 00:12We know that minority underserved
• 00:14populations really struggle with
• 00:16many aspects of cancer care,
• 00:18whether it's access to care,
• 00:20whether it is the psychosocial needs,
• 00:22whether it is their socioeconomic needs,
• 00:24and really just in terms of relatability
• 00:27about what they're experiencing from
• 00:29their own cancer diagnosis and their.
• 00:31Cancer journey and we really want
• 00:33this to be across the spectrum from
• 00:36the beginning of a cancer diagnosis
• 00:38all the way into survivorship
• 00:40across the board for patients.
• 00:41So we really want to ensure that we're
• 00:44addressing the needs of patients that
• 00:46are coming from diverse communities,
• 00:48from underserved populations
• 00:49and from minority populations.
• 00:50So the PROSPER study has really been
• 00:53designed to address the needs of minority
• 00:55and underserved populations first.
• 00:57So we are looking at patients that
• 00:59have an early onset cancer diagnosis,
• 01:01whether it's breast cancer or.
• 01:03Colorectal cancer,
• 01:04pancreatic cancer or prostate cancer
• 01:06and who are from black or African
• 01:08ancestry and also Hispanic Latin X
• 01:10or Spanish speaking individuals.
• 01:12And we're very excited to partner
• 01:14with our groups in the community
• 01:16to help really understand the needs
• 01:19of these individuals to be able to
• 01:21really bring forth programs and
• 01:23tools that are really meaningful,
• 01:25impactful and can really make
• 01:27a difference in terms of their
• 01:29cancer treatment and their journey
• 01:31into survivorship.